<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Filutowski Law Firm, PLLC &#187; pharmaceuticals</title>
	<atom:link href="http://www.filutowskilaw.com/tag/pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.filutowskilaw.com</link>
	<description>Dedicated To Protecting Individuals&#039; Rights</description>
	<lastBuildDate>Mon, 06 Feb 2012 18:02:24 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Pfizer Liabilities Continue to Grow</title>
		<link>http://www.filutowskilaw.com/2010/05/pfizer-liabilities-continue-to-grow/</link>
		<comments>http://www.filutowskilaw.com/2010/05/pfizer-liabilities-continue-to-grow/#comments</comments>
		<pubDate>Thu, 13 May 2010 23:00:34 +0000</pubDate>
		<dc:creator>Legal Blog</dc:creator>
				<category><![CDATA[Health Care Reform]]></category>
		<category><![CDATA[Law Updates]]></category>
		<category><![CDATA[Medical Care]]></category>
		<category><![CDATA[Products Liability]]></category>
		<category><![CDATA[U.S.]]></category>
		<category><![CDATA[bextra]]></category>
		<category><![CDATA[Class action]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Geodon]]></category>
		<category><![CDATA[lawsuit]]></category>
		<category><![CDATA[lyrica]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Robbins Geller Rudman & Dowd LLP]]></category>
		<category><![CDATA[Zyvox]]></category>

		<guid isPermaLink="false">http://www.filutowskilaw.com/?p=1253</guid>
		<description><![CDATA[Robbins Geller Rudman &#38; Dowd LLP today announced that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of shareholders of Pfizer Inc. Pfizer is a pharmaceutical company engaged in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals [...]]]></description>
		<wfw:commentRss>http://www.filutowskilaw.com/2010/05/pfizer-liabilities-continue-to-grow/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Food &amp; Drug Administration Seeks Public Opinion &#8211; Online Marketing</title>
		<link>http://www.filutowskilaw.com/2009/09/food-drug-administration-seeks-public-input-on-regulating-marketing-of-approved-products/</link>
		<comments>http://www.filutowskilaw.com/2009/09/food-drug-administration-seeks-public-input-on-regulating-marketing-of-approved-products/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 15:44:23 +0000</pubDate>
		<dc:creator>Alexandra</dc:creator>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Medical Care]]></category>
		<category><![CDATA[U.S.]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[online marketing regulation]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[social media regulation]]></category>

		<guid isPermaLink="false">http://www.filutowskilaw.com/?p=521</guid>
		<description><![CDATA[In a release today on National Public Radio (NPR), the FDA announces that it seeks public input on how to regulate company&#8217;s marketing and online advertising of FDA approved products. A lack of regulation has led to false, deceptive and misleading ads that pose a potential harm to consumers.  Earlier this year, a host of [...]]]></description>
		<wfw:commentRss>http://www.filutowskilaw.com/2009/09/food-drug-administration-seeks-public-input-on-regulating-marketing-of-approved-products/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

